Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Entresto
Sacubitril/Valsartan
Novartis
Main Therapeutic Indication : Cardiovascular
Currency : USD
2015 Revenue in Millions : 0
2014 Revenue in Millions : 21
Growth (%) : New Launch
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF